Join for Free!
112388 members
table of contents table of contents

Biology Articles » Virology » Hepatitis A: Old and New » References

- Hepatitis A: Old and New

1. Ambrosch, F., G. Wiedermann, F. E. André, A. Delem, H. Grepor, H. Hofmann, E. D'Hondt, M. Kundi, J. Wynen, and C. Kunz. 1994. Clinical and immunological investigation of a new combined hepatitis A and hepatitis B vaccine. J. Med. Virol. 44:452-456
2. Andersen, T. T. 1937. The etiology of hepatitis epidemica. Acta Med. Scand. 93:209-227.
3. Andre, F. E., E. D'Hondt, A. Delem, and A. Safary. 1992. Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings. Vaccine 10(Suppl. 1):S160-S168
4. Anonymous. 1988. Hepatitis A among drug abusers. Morb. Mortal. Wkly. Rep. 37:297-300, 305.
5. Anonymous. 1992. Hepatitis A among homosexual men---United States, Canada, and Australia. Morb. Mortal. Wkly. Rep. 41:155, 161-164.
6. Anonymous. 1995. Licensure of inactivated hepatitis A vaccine and recommendations for use among international travelers. Morb. Mortal. Wkly. Rep. 44:559-560
7. Anonymous. 1996. Hepatitis A among persons with hemophilia who received clotting factor concentrate---United States, September-December 1995. Morb. Mortal. Wkly. Rep. 45:29-32
8. Reference deleted.
9. Anonymous. 1996. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal. Wkly. Rep. 45(RR-15):1-30
10. Anonymous. 1997. Summary of notifiable diseases, United States 1997. Morb. Mortal. Wkly. Rep. 46:3, 10-13.
11. Anonymous. 1997. Hepatitis A associated with consumption of frozen strawberries---Michigan, March 1997. Morb. Mortal. Wkly. Rep. 46:, 295.
12. Anonymous. 1998. Summary of notifiable diseases, United States 1998. Morb. Mortal. Wkly. Rep. 47:7, 12-15.
13. Anonymous. 1999. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal. Wkly. Rep. 48(RR-12):1-37.
14. Anonymous. 1916. Jaundice at Alexandria. Br. Med. J. 1:320-321.
15. Anonymous. 1943. Epidemic hepatitis, or catarrhal jaundice. JAMA 123:636-637.
16. Anonymous. 1947. Homologous serum hepatitis. Lancet ii:691-692.
17. Arankalle, V. A., S. A. Tsarev, M. S. Chadha, D. W. Alling, S. U. Emerson, K. Banerjee, and R. H. Purcell. 1995. Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992. J. Infect. Dis. 17:447-450.
18. Arnal, C., J. M. Crance, C. Gantzer, L. Schwartzbrod, R. Deloince, and S. Billaudel. 1998. Persistence of infectious hepatitis A virus and its genome in artificial seawater. Zentbl. Hyg. Umweltmed. 201:279-284.
19. Arslan, M., R. H. Wiesner, J. J. Poterucha, J. B. Gross, and N. N. Zein. 1998. Hepatitis A (HAV) antibodies in liver transplant (OLT) recipients: evidence for loss of immunity posttransplantation. Hepatology 28:235A.
20. Asher, L. V. S., L. N. Binn, T. L. Mensing, R. H. Marchwicki, R. A. Vassell, and G. D. Young. 1995. Pathogenesis of hepatitis A in orally inoculated owl monkeys (Aotus trivirgatus). J. Med. Virol. 47:260-268
21. Ashida, M., and C. Hamada. 1997. Molecular cloning of the hepatitis A virus receptor from a simian cell line. J. Gen. Virol. 78:1565-1569
22. Asselah, T., J. Bernuau, and P. Marcellin. 1999. Prevalence of hepatitis C virus infection in patients hospitalized for hepatitis A. Ann. Intern. Med. 130:451
23. Ballesteros, J., R. Dal-Re, A. Gonzalez, and J. del Romero. 1996. Are homosexual males a risk group for hepatitis A infection in intermediate endemicity areas? Epidemiol. Infect. 117:145-148
24. Barber, H. 1937. Infective hepatic jaundice. Br. Med. J. 1:67-68.
25. Barrett, P. N., H. Meyer, I. Wachtel, J. Eibl, and F. Dorner. 1997. Inactivation of hepatitis A virus in plasma products by vapor heating. Transfusion 37:215-220
26. Behrens, R. H., and J. F. Doherty. 1993. Severe hepatitis A despite passive immunisation. Lancet 341:972
27. Beller, M. 1992. Hepatitis A outbreak in Anchorage, Alaska, traced to ice slush beverages. West. J. Med. 156:624-627
28. Berelowitz, G. J., A. P. Burgess, T. Thanabalasingham, I. M. Murray-Lyon, and D. J. Wright. 1995. Post-hepatitis syndrome revisited. J. Viral Hepatol. 2:133-138[
29. Berge, J. J., D. P. Drennan, R. J. Jacobs, A. Jakins, A. S. Meyerhoff, W. Stubblefield, and M. Weinberg. 2000. The cost of hepatitis A infections in American adolescents and adults in 1997. Hepatology 31:469-473
30. Bernal, W., H. M. Smith, and R. Williams. 1996. A community prevalence study of antibodies to hepatitis A and E in inner-city London. J. Med. Virol. 49:230-234
31. Black, F. L., and D. L. Jacobson. 1986. Hepatitis A antibody in an isolated Amerindian tribe fifty years after exposure. J. Med. Virol. 19:19-21
32. Bloch, A. B., S. L. Stramer, J. D. Smith, H. S. Margolis, H. A. Fields, T. W. McKinley, C. P. Gerba, J. E. Maynard, and R. K. Sikes. 1990. Recovery of hepatitis A virus from a water supply responsible for a common source outbreak of hepatitis A. Am. J. Public Health 80:428-430
33. Blumer, G. 1923. Infectious jaundice in the United States. JAMA 81:353-358.
34. Boggs, J. D., J. L. Melnick, M. E. Conrad, and B. F. Felsher. 1970. Viral hepatitis: clinical and tissue culture studies. JAMA 214:1041-1046
35. Bottiger, M., B. Christenson, and L. Grillner. 1997. Hepatitis A immunity in the Swedish population: a study of the prevalence of markers in the Swedish population. Scand. J. Infect. Dis. 29:99-102
36. Bowden, F. J., B. J. Currie, N. C. Miller, S. A. Locarnini, and V. L. Krause. 1994. Should aboriginals in the "top end" of the Northern Territory be vaccinated against hepatitis A? Med. J. Aust. 161:372-373
37. Bradley, D. W., H. A. Fields, K. A. McCaustland, J. E. Maynard, R. H. Decker, R. Whittington, and L. R. Overby. 1979. Serodiagnosis of viral hepatitis A by a modified competitive binding radioimmunoassay for immunoglobulin M anti-hepatitis A virus. J. Clin. Microbiol. 9:120-127
38. Bradley, D. W., J. E. Maynard, S. H. Hindman, C. L. Hornbeck, H. A. Fields, K. A. McCaustland, and E. H. Cook, Jr. 1977. Serodiagnosis of viral hepatitis A: detection of acute-phase immunoglobulin M anti-hepatitis A virus by radioimmunoassay. J. Clin. Microbiol. 5:521-530
39. Breningstall, G. N., and K. K. Belani. 1995. Acute transverse myelitis and brainstem encephalitis associated with hepatitis A infection. Pediatr. Neurol. 12:169-171
40. Bryan, J. P., and M. Nelson. 1994. Testing for antibody to hepatitis A to decrease the cost of hepatitis A prophylaxis with immune globulin or hepatitis A vaccines. Arch. Intern. Med. 154:663-668
41. Burkholder, B. T., V. G. Coronado, J. Brown, J. H. Hutto, C. N. Shapiro, B. Robertson, and B. A. Woodruff. 1995. Nosocomial transmission of hepatitis A in a pediatric hospital traced to an anti-hepatitis A virus-negative patient with immunodeficiency. Pediatr. Infect. Dis. J. 14:261-266
42. Cameron, J. D. S. 1943. Infective hepatitis. Q. J. Med. 12:139-155.
43. Chio, F., Jr., and A. A. Bakir. 1992. Acute renal failure in hepatitis A. Int. J. Artif. Organs 15:413-416
44. Clayson, E. T., B. L. Innis, K. S. Myint, R. Snitbhan, D. W. Vaughan, and M. P. Shrestha. 1995. Short report: relative risk of hepatitis A and E among foreigners in Nepal. Am. J. Trop. Med. Hyg. 52:506-507
45. Cobden, I., and O. F. James. 1986. A biphasic illness associated with acute hepatitis A virus infection. J. Hepatol. 2:19-23
46. Cockayne, E. A. 1912. Catarrhal jaundice, sporadic and epidemic, and its relation to acute yellow atrophy of the liver. Q. J. Med. 6:1-29.
47. Cohen, O., D. Mevorach, Z. Ackerman, and R. Oren. 1993. Thrombocytopenic purpura as a manifestation of acute hepatitis A. J. Clin. Gastroenterol. 17:166-167
48. Cohn, E. J., J. L. Oncley, L. E. Strong, W. L. Hughes, Jr., and S. H. Armstrong. 1944. Chemical, clinical, and immunological studies on the products of human plasma fractionation. I. The characterization of the protein fractions of human plasma. J. Clin. Investig. 23:417-432.
49. Conaty, S., P. Bird, G. Bell, E. Kraa, G. Grohmann, and J. M. McAnulty. 2000. Hepatitis A in New South Wales, Australia, from consumption of oysters: the first reported outbreak. Epidemiol. Infect. 124:121-130
50. Corey, L., and K. K. Holmes. 1980. Sexual transmission of hepatitis A in homosexual men: incidence and mechanism. N. Engl. J. Med. 302:435-438
51. Coulepis, A. G., S. A. Locarnini, N. I. Lehmann, and I. D. Gust. 1980. Detection of hepatitis A virus in the feces of patients with naturally acquired infection. J. Infect. Dis. 141:151-156
52. Coursaget, P., Y. Buisson, N. Enogat, R. Bercion, J. M. Baudet, P. Delmaire, D. Prigent, and J. Desrame. 1998. Outbreak of enterically transmitted hepatitis due to hepatitis A and hepatitis E viruses. J. Hepatol. 28:745-750
53. Coutinho, R., A. Lent, P. Albrecht-Van, T. Rijsdijk, N. Lelie, N. Nagelkerke, and H. Kuipers. 1983. Prevalence and incidence of hepatitis A among male homosexuals. Br. Med. J. 287:1743-1750
54. Cullinan, E. R. 1939. The epidemiology of jaundice. Proc. R. Soc. Med. 32:933-950.
55. Reference deleted.
56. Dalton, C. B., A. Haddix, R. E. Hoffman, and E. E. Mast. 1996. The cost of a food-borne outbreak of hepatitis A in Denver, Colo. Arch. Intern. Med. 156:1013-1016
57. Dan, M., and R. Yaniv. 1990. Cholestatic hepatitis, cutaneous vasculitis, and vascular deposits of immunoglobulin M and complement associated with hepatitis A virus infection. Am. J. Med. 89:103-104
58. Darwich, M. A., R. Faris, J. D. Clemens, M. R. Rao, and R. Edelman. 1996. High seroprevalence of hepatitis A, B, C, and E viruses in residents in an Egyptian village in the Nile Delta: a pilot study. Am. J. Trop. Med. Hyg. 54:554-558
59. Das, A. 1999. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries. Hepatology 29:548-552
60. Davis, L. E., J. E. Brown, B. H. Robertson, B. Khanna, and L. B. Polish. 1993. Hepatitis A post-viral encephalitis. Acta Neurol. Scand. 87:67-69
61. Davis, T. V., and E. B. Keeffe. 1992. Acute pancreatitis associated with acute hepatitis A. Am. J. Gastroenterol. 87:1648-1650
62. Debray, D., P. Cullufi, D. Devictor, M. Fabre, and O. Bernard. 1997. Liver failure in children with hepatitis A. Hepatology 26:1018-1022
63. Decker, R. H., S. M. Kosakowski, A. S. Vanderbilt, C. M. Ling, R. Chairez, and L. R. Overby. 1981. Diagnosis of acute hepatitis A by HAVAB-M, a direct radioimmunoassay for IgM anti-HAV. Am. J. Clin. Pathol. 76:140-147
64. Desenclos, J. C., K. C. Klontz, M. H. Wilder, O. V. Nainan, H. S. Margolis, and R. A. Gunn. 1991. A multistate outbreak of hepatitis A caused by the consumption of raw oysters. Am. J. Public Health 81:1268-1272
65. De Serres, G., and D. Laliberte. 1997. Hepatitis A among workers from a waste water treatment plant during a small community outbreak. Occup. Environ. Med. 54:60-62
66. Dible, J. H., J. McMichael, and S. P. V. Sherlock. 1943. Pathology of acute hepatitis: aspiration biopsy studies of epidemic, arsenotherapy and serum jaundice. Lancet ii:402-408.
67. Dienstag, J. L., S. M. Feinstone, A. Z. Kapikian, R. H. Purcell, J. D. Boggs, and M. E. Conrad. 1975. Faecal shedding of hepatitis-A antigen. Lancet ii:765-767.
68. Dienstag, J. L., I. D. Gust, C. R. Lucas, D. C. Wong, and R. H. Purcell. 1976. Mussel-associated viral hepatitis, type A: serological confirmation. Lancet i:561-564.
69. Dienstag, J. L., S. Krugman, D. C. Wong, and R. H. Purcell. 1976. Comparison of serological tests for antibody to hepatitis A antigen, using coded specimens from individuals infected with the MS-1 strain of hepatitis A virus. Infect. Immun. 14:1000-1003
70. Dienstag, J. L., J. A. Routenberg, R. H. Purcell, R. R. Hooper, and W. O. Harrison. 1975. Foodhandler-associated outbreak of hepatitis type A. An immune electron microscopy study. Ann. Intern. Med. 83:647-650
71. Divizia, M., V. Ruscio, A. M. Degener, and A. Pana. 1998. Hepatitis A virus detection in wastewater by PCR and hybridization. New Microbiol. 21:161-167
72. Doebbeling, B. N., N. Li, and R. P. Wenzel. 1993. An outbreak of hepatitis A among health care workers: risk factors for transmission. Am. J. Public Health 83:1679-1684
73. Domenech, P., A. Palomeque, A. Martinez-Gutierrez, N. Vinolas, E. Vela, and R. Jimenez. 1986. Severe aplastic anaemia following hepatitis A. Acta Haematol. 76:227-229
74. Erkan, T., T. Kutlu, F. Cullu, and G. T. Tumay. 1998. A case of vertical transmission of hepatitis A virus infection. Acta Paediatr. 87:1008-1009
75. Fagan, E., G. Yousef, J. Brahm, H. Garelick, G. Mann, A. Wolstenholme, B. Portmann, T. Harrison, J. F. Mowbray, A. Mowat, A. Zuckerman, and R. Williams. 1990. Persistence of hepatitis A virus in fulminant hepatitis and after liver transplantation. J. Med. Virol. 30:131-136
76. Faust, R. L., and N. Pimstone. 1996. Acute renal failure associated with nonfulminant hepatitis A viral infection. Am. J. Gastroenterol. 91:369-372
77. Feigelstock, D., P. Thompson, P. Mattoo, and G. G. Kaplan. 1998. Polymorphisms of the hepatitis A virus cellular receptor 1 in African green monkey kidney cells result in antigenic variants that do not react with protective monoclonal antibody 190/4. J. Virol. 72:6218-6222
78. Feinstone, S. M., A. Z. Kapikian, and R. H. Purcell. 1973. Hepatitis A: detection by immune electron microscopy of a virus-like antigen associated with acute illness. Science 182:1026-1028
79. Fikar, C. R., and C. McKee. 1994. False positivity of IgM antibody to Epstein-Barr viral capsid antigen during acute hepatitis A infection. Pediatr. Infect. Dis. 13:413-414.
80. Findlay, G. M., and J. L. Dunlop. 1932. A fatal case of acute necrosis of the liver associated with epidemic catarrhal jaundice. Br. Med. J. 1:652-656.
81. Findlay, G. M., J. L. Dunlop, and H. C. Brown. 1931. Observations on epidemic catarrhal jaundice. Trans. R. Soc. Trop. Med. Hyg. 25:7-24.
82. Findlay, G. M., and N. H. Martin. 1943. Jaundice following yellow-fever immunisation. Lancet i:678-680.
83. Fleischer, B., S. Fleischer, K. Maier, K. H. Wiedmann, M. Sacher, H. Thaler, and A. Vallbracht. 1990. Clonal analysis of infiltrating T lymphocytes in liver tissue in viral hepatitis A. Immunology 69:14-19
84. Ford, J. C. 1943. Infective hepatitis: 300 cases in an outer London borough. Lancet i:675-678.
85. Friedman, L. S., T. F. O'Brien, L. J. Morse, L. W. Chang, W. E. Wacker, D. M. Ryan, and J. L. Dienstag. 1985. Revisiting the Holy Cross football team hepatitis outbreak (1969) by serological analysis. JAMA 254:774-776
86. Gane, E., R. Sallie, M. Saleh, B. Portmann, and R. Williams. 1995. Clinical recurrence of hepatitis A following liver transplantation for acute liver failure. J. Med. Virol. 45:35-39
87. Gardner, P., T. Eickhoff, G. A. Poland, P. Gross, M. Griffin, F. M. LaForce, W. Schaffner, and R. Strikas. 1996. Adult immunizations. Ann. Intern. Med. 124:35-40.
88. Gaskell, J. F. 1933. The changes in the liver in a fatal case of epidemic "catarrhal" jaundice. J. Pathol. Bacteriol. 36:257-262.
89. Gellis, S. S., J. Stokes, Jr., G. M. Brother, W. M. Hall, H. R. Gilmore, E. Beyer, and R. A. Morrissey. 1945. The use of human immune serum globulin (gamma globulin) in infectious (epidemic) hepatitis in the Mediterranean theater of operations. I. Studies on prophylaxis in two epidemics of infectious hepatitis. JAMA 128:1062-1063.
90. Geltner, D., Y. Naot, O. Zimhoni, S. Gorbach, and Y. Bar-Khayim. 1992. Acute oliguric renal failure complicating type A nonfulminant viral hepatitis: a case presentation and review of the literature. J. Clin. Gastroenterol. 14:160-162
91. Glikson, M., E. Galun, R. Oren, R. Tur-Kaspa, and D. Shouval. 1992. Relapsing hepatitis A: review of 14 cases and literature survey. Medicine (Baltimore) 71:14-23
92. Glover, J. A., and J. Wilson. 1931. An extensive epidemic of catarrhal jaundice. Lancet i:722-725.
93. Goodman, R. A. 1985. Nosocomial hepatitis A. Ann. Intern. Med. 103:452-454
94. Goodman, R. A., C. C. Carder, J. R. Allen, W. A. Orenstein, and R. J. Finton. 1982. Nosocomial hepatitis A transmission by an adult patient with diarrhea. Am. J. Med. 73:220-226
95. Gordon, S. C., K. R. Reddy, L. Schiff, and E. R. Schiff. 1984. Prolonged intrahepatic cholestasis secondary to acute hepatitis A. Ann. Intern. Med. 101:635-637
96. Green, M. S., D. Cohen, Y. Lerman, M. Sjogren, L. N. Binn, S. Zur, R. Slepon, G. Robin, C. Hoke, W. Bancroft, A. Safary, Y. Danon, and M. Wiener. 1993. Depression of the immune response to an inactivated hepatitis A vaccine administered concomitantly with immune globulin. J. Infect. Dis. 168:740-743
97. Grinde, B., K. Stene-Johansen, B. Sharma, T. Hoel, M. Jensenius, and K. Skaug. 1997. Characterisation of an epidemic of hepatitis A virus involving intravenous drug abusers---infection by needle sharing? J. Med. Virol. 53:69-75
98. Gutzeit, K. 1950. Die hepatitis epidemica. Muench. Med. Wochenschr. 92:1295-1301.
99. Hadler, S. C., H. M. Webster, J. J. Erben, J. E. Swanson, and J. E. Maynard. 1980. Hepatitis A in day-care centers: a community-wide assessment. N. Engl. J. Med. 302:1222-1227
100. Halliday, M. L., L. Y. Kang, T. K. Zhou, M. D. Hu, Q. C. Pan, T. Y. Fu, Y. S. Huang, and S. L. Hu. 1991. An epidemic of hepatitis A attributable to the ingestion of raw clams in Shanghai, China. J. Infect. Dis. 164:852-859
101. Hanna, J. N., M. R. Loewenthal, P. Negel, and D. J. Wenck. 1996. An outbreak of hepatitis A in an intensive care unit. Anaesth. Intensive Care 24:440-444
102. Havens, W. P., Jr. 1944. Infectious hepatitis in the Middle East: a clinical review of 200 cases seen in a military hospital. JAMA 126:17-23.
103. Havens, W. P., Jr., and J. R. Paul. 1945. Prevention of infectious hepatitis with gamma globulin. JAMA 129:270-272.
104. Havens, W. P., Jr., R. Ward, V. A. Drill, and J. R. Paul. 1944. Experimental production of hepatitis by feeding icterogenic materials. Proc. Soc. Exp. Biol. Med. 57:206-208.
105. Havens, W. P. 1946. Period of infectivity of patients with experimentally induced infectious hepatitis. J. Exp. Med. 83:215-258.
106. Havens, W. P. 1947. The etiology of infectious hepatitis. JAMA 134:653-655.
107. Hawkins, R. E., J. D. Malone, L. A. Cloninger, P. J. Rozmajzl, D. Lewis, J. Butler, E. Cross, S. Gray, and K. C. Hyams. 1992. Risk of viral hepatitis among military personnel assigned to US Navy ships. J. Infect. Dis. 165:716-719
108. Helbling, B., E. L. Renner, and R. Kammerlander. 1999. Acute hepatitis A in patients with chronic hepatitis C. Ann. Intern. Med. 131:314
109. Henkel, J. 1999. Food firm gets huge fine for tainted strawberry harvest. FDA Consum. 33:37-38
110. Henning, K. J., E. Bell, J. Braun, and N. D. Barker. 1995. A community-wide outbreak of hepatitis A: risk factors for infection among homosexual and bisexual men. Am. J. Med. 99:132-136
111. Hess, G., R. Clemens, U. Bienzle, C. Schonfeld, B. Schunck, and H. L. Bock. 1995. Immunogenicity and safety of an inactivated hepatitis A vaccine in anti-HIV positive and negative homosexual men. J. Med. Virol. 46:40-42
112. Hirata, R., Y. Hoshino, H. Sakai, F. Marumo, and C. Sato. 1995. Patients with hepatitis A with negative IgM-HA antibody at early stages. Am. J. Gastroenterol. 90:1168-1169
113. Hoagland, C. L., and R. E. Shank. 1946. Infectious hepatitis: a review of 200 cases. JAMA 130:615-621.
114. Hodges, M., E. Sanders, and C. Aitken. 1998. Seroprevalence of hepatitis markers; HAV, HBV, HCV and HEV amongst primary school children in Freetown, Sierra Leone. West Afr. J. Med. 17:36-37
115. Hollinger, F. B., and J. Ticehurst. 1996. Hepatitis A virus, p. 735-782. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
116. Holmes, A. W., L. Wolfe, H. Rosenblate, and F. Deinhardt. 1969. Hepatitis in marmosets: induction of disease with coded specimens from a human volunteer study. Science 165:816-817
117. Holter, E., and J. C. Siebke. 1988. Hepatitis A in young Norwegian drug addicts and prison inmates. Infection 16:91-94
118. Hopkins, R. 1981. HBsAg-negative blood donors with a history of jaundice as a source of plasma for preparation of hyperimmune hepatitis type A globulin. J. Infect. 3:166-171
119. Huo, T. I., J. C. Wu, C. F. Chiu, and S. D. Lee. 1996. Severe hyperbilirubinemia due to acute hepatitis A superimposed on a chronic hepatitis B carrier with glucose-6-phosphate dehydrogenase deficiency. Am. J. Gastroenterol. 91:158-159
120. Huppertz, H. I., U. Treichel, A. M. Gassel, R. Jeschke, and K. H. Meyer zum Buschenfelde. 1995. Autoimmune hepatitis following hepatitis A virus infection. J. Hepatol. 23:204-208
121. Hutin, Y. J., V. Pool, E. H. Cramer, O. V. Nainan, J. Weth, I. T. Williams, S. T. Goldstein, K. F. Gensheimer, B. P. Bell, C. N. Shapiro, M. J. Alter, and H. S. Margolis. 1999. A multistate, foodborne outbreak of hepatitis A. National Hepatitis A Investigation Team. N. Engl. J. Med. 340:595-602
122. Ilan, Y., M. Hillman, R. Oren, A. Zlotogorski, and D. Shouval. 1990. Vasculitis and cryoglobulinemia associated with persisting cholestatic hepatitis A virus infection. Am. J. Gastroenterol. 85:586-587
123. Inman, R. D., M. Hodge, M. E. Johnston, J. Wright, and J. Heathcote. 1986. Arthritis, vasculitis, and cryoglobulinemia associated with relapsing hepatitis A virus infection. Ann. Intern. Med. 105:700-703
124. Innis, B. L., R. Snitbhan, P. Kunasol, T. Laorakpongse, W. Poopatanakool, C. A. Kozik, S. Suntayakorn, T. Suknuntapong, A. Safary, and J. W. Boslego. 1992. A field efficacy trial of inactivated hepatitis A vaccine among children in Thailand. Vaccine 10:S159
125. Innis, B. L., R. Snitbhan, P. Kunasol, T. Laorakpongse, W. Poopatanakool, C. A. Kozik, S. Suntayakorn, T. Suknuntapong, A. Safary, D. B. Tang, and J. W. Boslego. 1994. Protection against hepatitis A by an inactivated vaccine. JAMA 271:1328-1334
126. Inoue, K., M. Yoshiba, H. Yotsuyanagi, T. Otsuka, K. Sekiyama, and R. Fujita. 1996. Chronic hepatitis A with persistent viral replication. J. Med. Virol. 50:322-324
127. Ishak, K. G. 1976. Light microscopic morphology of viral hepatitis. Am. J. Clin. Pathol. 65:787-827.
128. Iversen, P., and K. Roholm. 1939. On aspiration biopsy of the liver, with remarks on its diagnostic significance. Acta Med. Scand. 102:1-16.
129. Jacobson, I. M., B. J. Nath, and J. L. Dienstag. 1985. Relapsing viral hepatitis type A. J. Med. Virol. 16:163-169
130. Kao, H. W., M. Ashcavai, and A. G. Redeker. 1984. The persistence of hepatitis A IgM antibody after acute clinical hepatitis A. Hepatology 4:933-936
131. Kaplan, G., A. Totsuka, P. Thompson, T. Akatsuka, Y. Moritsugu, and S. M. Feinstone. 1996. Identification of a surface glycoprotein on African green monkey kidney cells as a receptor for hepatitis A virus. EMBO J. 15:4282-4296
132. Katz, R., M. Velasco, C. Guzman, and H. Alessandri. 1964. Red cell survival estimated by radioactive chromium in hepatobiliary disease. Gastroenterology 46:399-404.
133. Keeffe, E. B. 1995. Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases? Am. J. Gastroenterol. 90:201-205
134. Keeffe, E. B., S. Iwarson, B. J. McMahon, K. L. Lindsay, R. S. Koff, M. Manns, R. Baumgarten, M. Wiese, M. Fourneau, A. Safary, R. Clemens, and D. S. Krause. 1998. Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease. Hepatology 27:881-886
135. Klein, B. S., J. A. Michaels, M. W. Rytel, K. G. Berg, and J. P. Davis. 1984. Nosocomial hepatitis A. A multinursery outbreak in Wisconsin. JAMA 252:2716-2721
136. Krook, A., J. Albert, S. Andersson, G. Biberfeld, J. Blomberg, I. Eklund, A. Engstrom, I. Julander, K. Kall, C. Martin, P. Stendahl, J. Struve, and A. Sonnerborg. 1997. Prevalence and risk factors for HTLV-II infection in 913 injecting drug users in Stockholm, 1994. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 15:381-386
137. Krugman, S., H. Friedman, and C. Lattimer. 1975. Identification by specific complement fixation and immune adherence tests. N. Engl. J. Med. 292:1141-1143
138. Krugman, S., J. P. Giles, and J. Hammond. 1967. Infectious hepatitis. Evidence for two distinctive clinical, epidemiological, and immunological types of infection. JAMA 200:365-373
139. Krugman, S., R. Ward, and J. P. Giles. 1962. The natural history of infectious hepatitis. Am. J. Med. 32:717-728.
140. Krugman, S., R. Ward, J. P. Giles, D. Bodansky, and A. M. Jacobs. 1959. Infectious hepatitis: detection of virus during the incubation period and in clinically inapparent infection. N. Engl. J. Med. 261:729-734.
141. Kryger, P., and P. Christoffersen. 1983. Liver histopathology of the hepatitis A virus infection: a comparison with hepatitis type B and non-A, non-B. J. Clin. Pathol. 36:650-654
142. Kurane, I., L. N. Binn, W. H. Bancroft, and F. A. Ennis. 1985. Human lymphocyte responses to hepatitis A virus-infected cells: interferon production and lysis of infected cells. J. Immunol. 135:2140-2144
143. LaBrecque, F. D., D. R. LaBrecque, D. Klinzman, S. Perlman, J. B. Cederna, P. L. Winokur, J. Q. Han, and J. T. Stapleton. 1998. Recombinant hepatitis A virus antigen: improved production and utility in diagnostic immunoassays. J. Clin. Microbiol. 36:2014-2018
144. Lednar, W. M., S. M. Lemon, J. W. Kirkpatrick, R. R. Redfield, M. L. Fields, and P. W. Kelley. 1985. Frequency of illness associated with epidemic hepatitis A virus infections in adults. Am. J. Epidemiol. 122:226-233
145. Lee, S. D., C. Y. Chan, M. I. Yu, Y. J. Wang, F. Y. Chang, K. J. Lo, and A. Safary. 1997. Safety and immunogenicity of inactivated hepatitis A vaccine in patients with chronic liver disease. J. Med. Virol. 52:215-218
146. Leikin, E., A. Lysikiewicz, D. Garry, and N. Tejani. 1996. Intrauterine transmission of hepatitis A virus. Obstet. Gynecol. 88:690-691
147. Lemon, S. M. 1994. Inactivated hepatitis A vaccines. JAMA 271:1363-1364
148. Lemon, S. M., R. W. Jansen, and E. A. Brown. 1992. Genetic, antigenic and biological differences between strains of hepatitis A virus. Vaccine 10(Suppl. 1):S40-S44
149. Lemon, S. M., and C. N. Shapiro. 1994. The value of immunization against hepatitis A. Infect. Agents Dis. 3:38-49
150. Lerman, Y., G. Chodik, H. Aloni, J. Ribak, and S. Ashkenazi. 1999. Occupations at increased risk of hepatitis A: a 2-year nationwide historical prospective study. Am. J. Epidemiol. 150:312-320
151. Levine, A. J. 1996. The origins of virology, p. 1-14. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
152. Lin, C. C., C. H. Chang, S. H. Lee, S. S. Chiang, and A. H. Yang. 1996. Acute renal failure in non-fulminant hepatitis A. Nephrol. Dial. Transplant. 11:2061-2066
153. Linder, C. R., Y. V. Karetnyi, J. Kuint, E. Mendelson, and R. Dagan. 1995. Symptomatic hepatitis A virus infection during the first year of life. Pediatr. Infect. Dis. 14:628-629.
154. Lisney, A. A. 1937. Epidemic catarrhal jaundice in school children. Br. Med. J. 1:703-706.
155. Lowry, P. W., R. Levine, D. F. Stroup, R. A. Gunn, M. H. Wilder, and C. Konigsberg, Jr. 1989. Hepatitis A outbreak on a floating restaurant in Florida, 1986. Am. J. Epidemiol. 129:155-164
156. Lyons, D. J., J. M. Gilvarry, and J. F. Fielding. 1990. Severe haemolysis associated with hepatitis A and normal glucose-6-phosphate dehydrogenase status. Gut 31:838-839
157. Mahoney, F. J., T. A. Farley, K. Y. Kelso, S. A. Wilson, J. M. Horan, and L. M. McFarland. 1992. An outbreak of hepatitis A associated with swimming in a public pool. J. Infect. Dis. 165:613-618
158. Mallory, T. B. 1947. The pathology of epidemic hepatitis. JAMA 134:655-662.
159. Mannucci, P. M., S. Gdovin, A. Gringeri, M. Colombo, A. Mele, N. Schinaia, N. Ciavarella, S. U. Emerson, and R. H. Purcell. 1994. Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. The Italian Collaborative Group. Ann. Intern. Med. 120:1-7
160. Margolis, H. S., and O. V. Nainan. 1990. Identification of virus components in circulating immune complexes isolated during hepatitis A virus infection. Hepatology 11:31-37
161. Martin, C. J. 1917. Concerning the pathology and etiology of the infectious jaundice common at the Dardenelles, 1915. Br. Med. J. 1:445.
162. Reference deleted.
163. Mbithi, J. N., V. S. Springthorpe, J. R. Boulet, and S. A. Sattar. 1992. Survival of hepatitis A virus on human hands and its transfer on contact with animate and inanimate surfaces. J. Clin. Microbiol. 30:757-763
164. McCann, U. G., 2nd, F. Rabito, M. Shah, C. R. Nolan, 3rd, and M. Lee. 1996. Acute renal failure complicating nonfulminant hepatitis A. West. J. Med. 165:308-310
165. McDonald, G. S., M. G. Courtney, A. G. Shattock, and D. G. Weir. 1989. Prolonged IgM antibodies and histopathological evidence of chronicity in hepatitis A. Liver 9:223-228
166. McDonald, S. 1908. Acute yellow atrophy of the liver. Edin. Med. J. 1:83-88.
167. McKhann, C. F. 1937. The prevention and modification of measles. JAMA 109:234.
168. McMahon, B. J., M. Beller, J. Williams, M. Schloss, H. Tanttila, and L. Bulkow. 1996. A program to control an outbreak of hepatitis A in Alaska by using an inactivated hepatitis A vaccine. Arch. Pediatr. Adolesc. Med. 150:733-739
169. Medawar, P. B., and J. S. Medawar. 1983. Viruses, p. 275. In P. B. Medawar, and J. S. Medawar (ed.), Aristotle to zoos: a philosophical dictionary of biology. Harvard University Press, Cambridge, Mass.
170. Meyers, J. D., J. C. Huff, K. K. Holmes, E. D. Thomas, and J. A. Bryan. 1974. Parenterally transmitted hepatitis A associated with platelet transfusions: epidemiologic study of an outbreak in a marrow transplantation center. Ann. Intern. Med. 81:145-151
171. Midthun, K., E. Ellerbeck, K. Gershman, G. Calandra, D. Krah, M. McCaughtry, D. Nalin, and P. Provost. 1991. Safety and immunogenicity of a live attenuated hepatitis A virus vaccine in seronegative volunteers. J. Infect. Dis. 163:735-739
172. Miller, W. J., P. J. Provost, W. J. McAleer, O. L. Ittensohn, V. M. Villarejos, and M. R. Hillmean. 1975. Specific immune adherence assay for human hepatitis A antibody. Application to diagnostic and epidemiologic investigations. Proc. Soc. Exp. Biol. Med. 149:254-261
173. Molner, J. G., and M. F. Meyer. 1940. Jaundice in Detroit. Am. J. Public Health 30:509-515.
174. Morales, J. L., L. Huber, S. Gallego, G. Alvarez, J. Diez-Delgado, A. Gonzalez, L. Aguilar, and R. Dal-Re. 1992. A seroepidemiologic study of hepatitis A in Spanish children: relationship to age and socio-environmental factors. Infection 20:194-196
175. Mosley, J. W., K. A. Visoná, and V. M. Villarejos. 1981. Immunoglobulin M level in the diagnosis of type A hepatitis. Am. J. Clin. Pathol. 75:86-87
176. Mourani, S., S. M. Dobbs, R. M. Genta, A. K. Tandon, and B. Yoffe. 1994. Hepatitis A virus-associated cholecystitis. Ann. Intern. Med. 120:398-400
177. Neefe, J. R., and J. Stokes, Jr. 1945. An epidemic of infectious hepatitis apparently due to a water-borne agent. JAMA 128:1063-1075.
178. Neilsen, G. A., N. J. Bodsworth, and N. Watts. 1997. Response to hepatitis A vaccination in human immunodeficiency virus-infected and -uninfected homosexual men. J. Infect. Dis. 176:1064-1067
179. Niu, M. T., L. B. Polish, B. H. Robertson, B. K. Khanna, B. A. Woodruff, C. N. Shapiro, M. A. Miller, J. D. Smith, J. K. Gedrose, M. J. Alter, H. S. Margolis, and the National Hepatitis A Investigation Team. 1992. Multistate outbreak of hepatitis A associated with frozen strawberries. J. Infect. Dis. 166:518-524
180. Noble, R. C., M. A. Kane, S. A. Reeves, and I. Roeckel. 1984. Posttransfusion hepatitis A in a neonatal intensive care unit. JAMA 252:2711-2715
181. Norton, J. A. 1939. Acute infectious jaundice. JAMA 113:916-917.
182. Ochnio, J. J., D. W. Scheifele, M. Ho, and L. A. Mitchell. 1997. New, ultrasensitive enzyme immunoassay for detecting vaccine- and disease-induced hepatitis A virus-specific immunoglobulin G in saliva. J. Clin. Microbiol. 35:98-101
183. O'Connor, J. B., T. F. Imperiale, and M. E. Singer. 1999. Cost-effectiveness analysis of hepatitis A vaccination strategies for adults. Hepatology 30:1077-1081
184. Okuno, T., A. Sano, T. Deguchi, Y. Katsuma, T. Ogasawara, T. Okanoue, and T. Takino. 1984. Pathology of acute hepatitis A in humans. Comparison with acute hepatitis B. Am. J. Clin. Pathol. 81:162-169
185. Oldstone, M. B. A. (ed.). 1998. Viruses, plagues, and history. Oxford University Press, New York, N.Y.
186. O'Mahony, M. C., C. D. Gooch, D. A. Smyth, A. J. Thrussell, C. L. R. Bartlett, and N. D. Noah. 1983. Epidemic hepatitis A from cockles. Lancet i:518-520.
187. Ordman, C. W., C. G. Jennings, Jr., and C. A. Janeway. 1944. Chemical, clinical, and immunological studies on the products of human plasma fractionation. XII. Use of concentrated normal human serum gamma globulin (human immune serum globulin) in the prevention and attenuation of measles. J. Clin. Investig. 23:541-549.
188. Paul, J. R., and H. T. Gardner. 1960. Viral hepatitis: communicable diseases transmitted through contact or by unknown means, p. 411-462. In E. C. Hoff, and J. B. Coates, Jr. (ed.), Preventive medicine in World War II, vol. V. Office of the Surgeon General, Department of the Army, Washington, D.C.
189. Paul, J. R., and W. P. Havens, Jr. 1946. Recent advances in the study of infectious hepatitis and serum jaundice. Trans. Assoc. Am. Phys. 59:133-141.
190. Paul, J. R., W. P. Havens, A. B. Sabin, and C. B. Philip. 1945. Transmission experiments in serum jaundice and infectious hepatitis. JAMA 128:911-915.
191. Pavia, A. T., L. Nielsen, L. Armington, D. J. Thurman, E. Tierney, and C. R. Nichols. 1990. A community-wide outbreak of hepatitis A in a religious community: impact of mass administration of immune globulin. Am. J. Epidemiol. 131:1085-1093
192. Pebody, R. G., T. Leino, P. Ruutu, L. Kinnunen, I. Davidkin, H. Nohynek, and P. Leinikki. 1998. Foodborne outbreaks of hepatitis A in a low endemic country: an emerging problem? Epidemiol. Infect. 120:55-59
193. Pelletier, G., D. Elghozi, C. Trepo, C. Laverdant, and J. P. Benhamou. 1985. Mononeuritis in acute viral hepatitis. Digestion 32:53-56
194. Perez, O. M., W. Morales, M. Paniagua, and O. Strannegard. 1996. Prevalence of antibodies to hepatitis A, B, C, and E viruses in a healthy population in Leon, Nicaragua. Am. J. Trop. Med. Hyg. 55:17-21
195. Petersen, P., P. Christoffersen, P. Elling, E. Juhl, O. Dietrichson, V. Faber, K. Iversen, J. O. Nielsen, and H. Poulsen. 1974. Clinical, biochemical, immunological, and morphological features at time of diagnosis. Scand. J. Gastroenterol. 9:607-613
196. Pickles, W. N. 1930. Epidemic catarrhal jaundice: an outbreak in Yorkshire. Br. Med. J. 1:944-946.
197. Ponz, E., J. C. Garcia-Pagan, M. Bruguera, J. Bruix, and J. Rodes. 1991. Hepatic fibrin-ring granulomas in a patient with hepatitis A. Gastroenterology 100:268-270
198. Príkazsky, V., V. Oleár, A. Cernoch, A. Safary, and F. E. Andre. 1994. Interruption of an outbreak of hepatitis A in two villages by vaccination. J. Med. Virol. 44:457-459
199. Probst, C., M. Jecht, and V. Gauss-Muller. 1999. Intrinsic signals for the assembly of hepatitis A virus particles: role of structural proteins VP4 and 2A. J. Biol. Chem. 274:4527-4531
200. Provost, J. J., O. L. Ittensohn, V. M. Villarejos, and M. R. Hilleman. 1975. A specific complement-fixation test for human hepatitis A employing CR 326 virus antigen. Diagnosis and epidemiology. Proc. Soc. Exp. Biol. Med. 148:962-968
201. Provost, P. J., and M. R. Hilleman. 1979. Propagation of human hepatitis A virus in cell culture in vitro. Proc. Soc. Exp. Biol. Med. 160:213-221.
202. Purcell, R. H. 1994. Hepatitis viruses: changing patterns of human disease. Proc. Natl. Acad. Sci. USA 91:2401-2406
203. Purcell, R. H., D. C. Wong, Y. Moritsugu, J. L. Dienstag, J. A. Routenberg, and J. D. Boggs. 1976. A microtiter solid phase radioimmunoassay for hepatitis A antigen and antibody. J. Immunol. 116:349-356
204. Rahaman, S. M., P. Chira, and R. S. Koff. 1994. Idiopathic autoimmune chronic hepatitis triggered by hepatitis A. Am. J. Gastroenterol. 89:106-108
205. Rajan, E., A. G. Shattock, and J. F. Fielding. 2000. Cost-effective analysis of hepatitis A prevention in Ireland. Am. J. Gastroenterol. 95:223-226
206. Reed, W. 1902. Recent researches concerning the etiology, propagation, and prevention of yellow fever by the United States Army Commission. J. Hyg. 2:101-119.
207. Repsher, L. H., and R. K. Freebern. 1969. Effects of early and vigorous exercise on recovery from infectious hepatitis. N. Engl. J. Med. 281:1393-1396
208. Ritter, K., A. Uy, S. Ritter, and R. Thomssen. 1994. Hemolysis and autoantibodies to triosephosphate isomerase in a patient with acute hepatitis A virus infection. Scand. J. Infect. Dis. 26:379-382
209. Ritter, S., S. Schroder, A. Uy, and K. Ritter. 1996. Haemolysis in hepatitis A virus infections coinciding with the occurrence of autoantibodies against triosephosphate isomerase and the reactivation of latent persistent Epstein-Barr virus infection. J. Med. Virol. 50:272-275
210. Robertson, B. H., X. Y. Jia, H. Tian, H. S. Margolis, D. F. Summers, and E. Ehrenfeld. 1993. Antibody response to nonstructural proteins of hepatitis A virus following infection. J. Med. Virol. 40:76-82
211. Rolleston, R. D. 1905. Diseases of the liver. In Encyclopedia medica.
212. Rosenblum, L. S., I. R. Mirkin, D. T. Allen, S. Safford, and S. C. Hadler. 1990. A multifocal outbreak of hepatitis A traced to commercially distributed lettuce. Am. J. Public Health 80:1075-1079
213. Rosenblum, L. S., M. E. Villarino, O. V. Nainan, M. E. Melish, S. C. Hadler, P. P. Pinsky, W. R. Jarvis, C. E. Ott, and H. S. Margolis. 1991. Hepatitis A outbreak in a neonatal intensive care unit: risk factors for transmission and evidence of prolonged viral excretion among preterm infants. J. Infect. Dis. 164:476-482
214. Routenberg, J. A., J. L. Dienstag, W. O. Harrison, M. E. Kilpatrick, R. R. Hooper, F. V. Chisari, R. H. Purcell, and M. F. Fornes. 1979. Foodborne outbreak of hepatitis A: clinical and laboratory features of acute and protracted illness. Am. J. Med. Sci. 278:123-137
215. Safadi, R., T. Ben-Hur, and D. Shouval. 1996. Mononeuritis multiplex: a rare complication of acute hepatitis A. Liver 16:288-289
216. Scheutz, F., P. Skinhrj, and I. Mark. 1983. Viral hepatitis among parenteral drug addicts attending a Danish addiction clinic. Scand. J. Infect. Dis. 15:139-143
217. Schiodt, F. V., E. Atillasoy, A. Obaid Shakil, E. R. Schiff, C. Caldwell, K. V. Kowdley, R. Stribling, J. S. Crippen, S. Flamm, K. A. Somberg, H. Rosen, T. M. McCashland, J. E. Hay, W. M. Lee, and the Acute Liver Failure Study Group. 1999. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transplant. Surg. 5:29-34
218. Sherertz, R. J., B. A. Russell, and P. D. Reuman. 1984. Transmission of hepatitis A by transfusion of blood products. Arch. Intern. Med. 144:1579-1580
219. Siddiqui, T., and A. H. Khan. 1998. Hepatitis A and cytomegalovirus infection precipitating acute hemolysis in glucose-6-phosphate dehydrogenase deficiency. Mil. Med. 163:434-435
220. Sikuler, E., A. Keynan, N. Hanuka, G. Zagron-Bachir, and I. Sarov. 1987. Persistence of a positive test for IgM antibodies to hepatitis A virus in late convalescent sera. Isr. J. Med. Sci. 23:193-195
221. Simmons, J., L. Stein, and A. Kaufman. 1993. Pure red cell aplasia and hepatitis A. South. Med. J. 86:1274-1276
222. Sjogren, M. H., C. H. Hoke, L. N. Binn, K. H. Eckels, D. R. Dubois, L. Lyde, A. Tsuchida, S. Oaks, Jr., R. Marchwicki, W. Lednar, R. Chloupek, J. Ticehurst, and W. H Bancroft. 1991. Immunogenicity of an inactivated hepatitis A vaccine. Ann. Intern. Med. 114:470-471
223. Sjogren, M. H., H. Tanno, O. Fay, S. Sileoni, B. D. Cohen, D. S. Burke, and R. J. Feighny. 1987. Hepatitis A virus in stool during clinical relapse. Ann. Intern. Med. 106:221-226
224. Smart, C. 1888. Medical history, part III, being the third medical volume, p. 874-879. In The medical and surgical history of the war of the rebellion, vol. I. Government Printing Office, Washington, D.C.
225. Smetana, H. F. 1954. The histologic diagnosis of viral heptatitis by needle biopsy. Gastroenterology 26:612-625.
226. Smith, P. F., J. C. Grabau, A. Werzberger, R. A. Gunn, H. R. Rolka, S. F. Kondracki, R. J. Gallo, and D. L. Morse. 1997. The role of young children in a community-wide outbreak of hepatitis A. Epidemiol. Infect. 118:243-252
227. Reference deleted.
228. Stapleton, J. T. 1995. Host immune response to hepatitis A virus. J. Infect. Dis. 171:S9-S14
229. Stapleton, J. T., D. K. Lange, J. W. LeDuc, L. N. Binn, R. W. Jansen, and S. M. Lemon. 1991. The role of secretory immunity in hepatitis A virus infection. J. Infect. Dis. 163:7-11
230. Steffen, R., M. A. Kane, C. N. Shapiro, N. Billo, K. J. Schoellhorn, and P. van Damme. 1994. Epidemiology and prevention of hepatitis A in travelers. JAMA 272:885-889
231. Stokes, J., Jr., J. A. Farquhar, M. E. Drake, et al. 1951. Infectious hepatitis: length of protection by immune serum globulin (gamma globulin) during epidemics. JAMA 147:714-719.
232. Stokes, J., Jr., E. P. Maris, and S. S. Gelliss. 1944. Chemical, clinical, and immunological studies on the products of human plasma fractionation. XI. Use of concentrated normal human serum gamma globulin (human immune serum globulin) in the prophylaxis and treatment of measles. J. Clin. Investig. 23:531-540.
233. Stokes, J., Jr., and J. R. Neefe. 1945. The prevention and attenuation of infectious hepatitis with gamma globulin (preliminary note). JAMA 127:144-145.
234. Storch, G. A., C. Bodicky, M. Parker, L. J. Blecka, and R. D. Aach. 1982. Use of conventional and IgM-specific radioimmunoassays for anti-hepatitis A antibody in an outbreak of hepatitis A. Am. J. Med. 73:663-668
235. Stroffolini, T., M. Chiaramonte, E. Franco, M. Rapicetta, D. De Mattia, I. Mura, R. Trivello, A. Giammeco, G. Rigo, and B. Scarpa. 1991. Baseline seroepidemiology of hepatitis A virus infection among children and teenagers in Italy. Infection 19:97-100
236. Sundkvist, T., C. Aitken, G. Duckworth, and D. Jeffries. 1997. Outbreak of acute hepatitis A among homosexual men in East London. Scand. J. Infect. Dis. 29:211-212
237. Sundkvist, T., B. Johansson, and A. Widell. 1985. Rectum carried drugs may spread hepatitis A among drug addicts. Scand. J. Infect. Dis. 17:1-4
238. Szmuness, W., J. L. Dienstag, R. H. Purcell, E. J. Harley, C. E. Stevens, and D. C. Wong. 1976. Distribution of antibody to hepatitis A antigen in urban adult populations. N. Engl. J. Med. 295:755-759
239. Tabor, E. 1987. Guillain-Barré syndrome and other neurologic syndromes in hepatitis A, B, and non-A, non-B. J. Med. Virol. 21:207-216
240. Tanno, H., O. H. Fay, J. A. Rojman, and J. Palazzi. 1988. Biphasic form of hepatitis A virus infection: a frequent variant in Argentina. Liver 8:53-57
241. Taylor, M., R. D. Goldin, S. Ladva, P. J. Scheuer, and H. C. Thomas. 1994. In situ hybridization studies of hepatitis A viral RNA in patients with acute hepatitis A. J. Hepatol. 20:380-387
242. Teixeira, M. R., Jr., I. V. Weller, A. Murray, M. Bamber, H. C. Thomas, S. Sherlock, and P. J. Scheuer. 1982. The pathology of hepatitis A in man. Liver 2:53-60
243. Thomas, W. J., P. Bruno, and K. Holtzmuller. 1993. Hepatitis A virus anicteric encephalitis coexistent with hepatitis C virus infection. Am. J. Gastroenterol. 88:279-281
244. Tibble, J. A., A. Ireland, and J. R Duncan. 1997. Acute auto immune haemolytic anaemia secondary to hepatitis A infection. Clin. Lab. Haematol. 19:73-75
245. Ticehurst, J. R., S. M. Feinstone, T. Chestnut, N. C. Tassopoulos, H. Popper, and R. H. Purcell. 1987. Detection of hepatitis A virus by extraction of viral RNA and molecular hybridization. J. Clin. Microbiol. 25:1822-1829
246. Tong, M. J., N. S. el-Farra, and M. I. Grew. 1995. Clinical manifestations of hepatitis A: recent experience in a community teaching hospital. J. Infect. Dis. 171(Suppl. 1):S15-S18
247. Trout, D., C. Mueller, L. Venczel, and A. Krake. 2000. Evaluation of occupational transmission of hepatitis A virus among wastewater workers. J. Occup. Environ. Med. 42:83-87
248. Tsai, J. F., H. S. Margolis, J. E. Jeng, M. S. Ho, W. Y. Chang, M. Y. Hsieh, Z. Y. Lin, and J. H. Tsai. 1996. Increased IgM class circulating immune complexes in acute hepatitis A virus infection. Clin. Immunol. Immunopathol. 78:291-295
249. Vallbracht, A., P. Gabriel, K. Maier, F. Hartmann, H. J. Steinhardt, C. Muller, A. Wolf, K. H. Manncke, and B. Flehmig. 1986. Cell-mediated cytotoxicity in hepatitis A virus infection. Hepatology 6:1308-1314
250. Van Damme, P., S. Thoelen, M. Cramm, K. De Groote, A. Safary, and A. Meheus. 1994. Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence. J. Med. Virol. 44:446-451
251. Van Doorslaer, E., G. Tormans, and P. Van Damme. 1994. Cost-effectiveness analysis of vaccination against hepatitis A in travellers. J. Med. Virol. 44:463-469
252. Vento, S., T. Garofano, G. Di Perri, L. Dolci, E. Concia, and D. Bassetti. 1991. Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals. Lancet 337:1183-1187
253. Vento, S., T. Garofano, C. Renzini, F. Cainelli, F. Casali, G. Ghironzi, T. Ferraro, and E. Concia. 1998. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N. Engl. J. Med. 338:286-290
254. Villano, S. A., K. E. Nelson, D. Vlahov, R. H. Purcell, A. J. Saah, and D. L. Thomas. 1997. Hepatitis A among homosexual men and injection drug users: more evidence for vaccination. Clin. Infect. Dis. 25:726-728
255. Voegt, H. 1942. Zur aetiologie der hepatitis epidemica. Muench. Med. Wochenschr. 89:76-79.
256. Wang, C. H., S. Y. Tschen, U. Heinricy, M. Weber, and B. Flehmig. 1996. Immune response to hepatitis A virus capsid proteins after infection. J. Clin. Microbiol. 34:707-713
257. Ward, R., S. Krugman, J. P. Giles, A. M. Jacobs, and O. Bodansky. 1958. Infectious hepatitis: studies of its natural history and prevention of viral hepatitis. N. Engl. J. Med. 258:407-416.
258. Watson, J. C., D. W. Fleming, A. J. Borella, E. S. Olcott, R. E. Conrad, and R. C. Baron. 1993. Vertical transmission of hepatitis A resulting in an outbreak in a neonatal intensive care unit. I. Infect. Dis. 167:567-571.
259. Weisfuse, I. B., D. J. Graham, M. Will, D. Parkinson, D. R. Snydman, M. Atkins, R. A. Karron, S. Feinstone, A. A. Rayner, R. I. Fisher, B. J. Mills, J. P. Dutcher, G. R. Weiss, A. Glover, J. N. Kuritsky, and S. C. Hadler. 1990. An outbreak of hepatitis A among cancer patients treated with interleukin-2 and lymphokine-activated killer cells. J. Infect. Dis. 161:647-652
260. Werzberger, A., B. Mensch, B. Kuter, L. Brown, J. Lewis, R. Sitrin, W. Miller, D. Shouval, B. Wiens, G. Calandra, J. Ryan, P. Provost, and D. Nalin. 1992. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N. Engl. J. Med. 327:453-457
261. Widell, A., B. G. Hansson, T. Moestrup, and E. Nordenfeldt. 1983. Increased occurrence of hepatitis A with cyclic outbreaks among drug addicts in a Swedish community. Infection 11:198-200
262. Willcox, W. H. 1916. The epidemic jaundice of campaigns. Br. Med. J. 1:297-300.
263. Willcox, W. H. 1919. Jaundice: with special reference to types occurring during the war. Lecture III, part I: epidemic catarrhal jaundice. Br. Med. J. 1:671-675.
264. Willner, I. R., M. D. Uhl, S. C. Howard, E. Q. Williams, C. A. Riely, and B. Waters. 1998. Serious hepatitis A: an analysis of patients hospitalized during an urban epidemic in the United States. Ann. Intern. Med. 128:111-114
265. Winokur, P. L., and J. T. Stapleton. 1992. Immunoglobulin prophylaxis for hepatitis A. Clin. Infect. Dis. 14:580-586
266. Witts, L. J. 1944. Some problems of infective hepatitis. Br. Med. J. 1:739-743.
267. Wróblewski, F., and J. S. LaDue. 1955. Serum glutamic oxaloacetic transaminase activity as an index of liver cell injury: a preliminary report. Ann. Intern. Med. 43:345-360.
268. Yamamoto, T., M. Ishii, H. Nagura, Y. Miyazaki, M. Miura, T. Igarashi, and T. Toyota. 1995. Transient hepatic fibrin-ring granulomas in a patient with acute hepatitis A. Liver 15:276-279
269. Yotsuyanagi, H., K. Koike, K. Yasuda, K. Moriya, Y. Shintani, H. Fujie, K. Kurokawa, and S. Iino. 1996. Prolonged fecal excretion of hepatitis A virus in adult patients with hepatitis A as determined by polymerase chain reaction. Hepatology 24:10-13
270. Zaaijer, H. L., A. Leentvaar-Kuijpers, H. Rotman, and P. N. Lelie. 1993. Hepatitis A antibody titres after infection and immunization: implications for passive and active immunization. J. Med. Virol. 40:22-27
271. Zikos, D., K. S. Grewal, K. Craig, J. C. Cheng, D. R. Peterson, and K. A. Fisher. 1995. Nephrotic syndrome and acute renal failure associated with hepatitis A virus infection. Am. J. Gastroenterol. 90:295-298
272. Zuckerman, A. J. 1969. Viral hepatitis and the Australia-SH antigen. Nature 223:569-572

rating: 3.58 from 19 votes | updated on: 20 Dec 2006 | views: 36340 |

Rate article: